Wilson Martin, General Counsel at Rocket Pharmaceuticals ($RCKT), sold common shares on the open market eight times in the last 365 days, totaling $101,440. His most recent sale occurred on February 18, 2026. These $RCKT insider sales rank 9,556th among 11,678 individual insiders, where the average is $8.6 million across 6.37 transactions. Wilson Martin made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 1376 | $3.34 | 682,000.0000 | 111,571,136 | 0.20% | 0.00% |
| Feb. 13, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 12253 | $3.31 | 683,376.0000 | 111,571,136 | 1.76% | 0.01% |
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Stock Option (Right to Buy) | 468187 | $0.00 | 468,187.0000 | 111,571,136 | 9999.99% | 0.42% |
| Feb. 11, 2026 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Common Stock | 311813 | $0.00 | 695,629.0000 | 111,571,136 | 81.24% | 0.28% |
| Nov. 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 1646 | $2.98 | 383,816.0000 | 111,571,136 | 0.43% | 0.00% |
| Nov. 3, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Common Stock | 100000 | $0.00 | 385,462.0000 | 111,571,136 | 35.03% | 0.09% |
| Sept. 8, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Common Stock | 150000 | $0.00 | 285,462.0000 | 94,807,773 | 110.73% | 0.16% |
| Aug. 18, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 1004 | $3.07 | 136,050.0000 | 94,807,773 | 0.73% | 0.00% |
| Aug. 19, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 588 | $3.00 | 135,462.0000 | 94,807,773 | 0.43% | 0.00% |
| Aug. 14, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 12109 | $3.02 | 137,054.0000 | 94,807,773 | 8.12% | 0.01% |
| May 20, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 587 | $6.45 | 149,163.0000 | 94,807,773 | 0.39% | 0.00% |
| May 16, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 946 | $6.53 | 149,750.0000 | 94,807,773 | 0.63% | 0.00% |
| Feb. 21, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 3222 | $10.58 | 150,696.0000 | 94,807,773 | 2.09% | 0.00% |
| Feb. 11, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Common Stock | 90358 | $0.00 | 153,918.0000 | 94,807,773 | 142.16% | 0.10% |
| Feb. 11, 2025 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Stock Option (Right to Buy) | 134642 | $0.00 | 134,642.0000 | 94,807,773 | 9999.99% | 0.14% |
| Nov. 21, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 1175 | $13.05 | 63,560.0000 | 94,158,491 | 1.82% | 0.00% |
| Aug. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 1027 | $18.50 | 64,735.0000 | 84,009,004 | 1.56% | 0.00% |
| May 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | M | Common Stock | 2420 | $0.00 | 21,100.0000 | 84,009,004 | 12.96% | 0.00% |
| Feb. 14, 2023 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | J | Restricted Stock Units | 16947 | $0.00 | 0.0000 | 68,148,925 | 100.00% | 0.02% |
| Aug. 12, 2022 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | J | Restricted Stock Units | 28763 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | M | Restricted Stock Units | 2420 | $0.00 | 16,947.0000 | 84,009,004 | 12.50% | 0.00% |
| May 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 1048 | $23.35 | 65,762.0000 | 84,009,004 | 1.57% | 0.00% |
| Feb. 14, 2023 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | J | Common Stock | 16947 | $0.00 | 66,810.0000 | 68,148,925 | 33.99% | 0.02% |
| Aug. 12, 2022 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | J | Common Stock | 28763 | $0.00 | 49,863.0000 | 0 | 136.32% | 0.00% |
| Feb. 29, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 4100 | $29.33 | 18,680.0000 | 84,009,004 | 18.00% | 0.00% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | S | Common Stock | 3576 | $29.84 | 6,136.0000 | 84,009,004 | 36.82% | 0.00% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Common Stock | 16644 | $0.00 | 22,780.0000 | 84,009,004 | 271.25% | 0.02% |
| Feb. 16, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | A | Stock Option (Right to Buy) | 49091 | $0.00 | 49,091.0000 | 84,009,004 | 9999.99% | 0.06% |
| Feb. 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | M | Common Stock | 9712 | $0.00 | 9,712.0000 | 84,009,004 | 50.00% | 0.01% |
| Feb. 14, 2024 | ROCKET PHARMACEUTICALS, INC. | $RCKT | Wilson Martin | General Counsel | M | Restricted Stock Units | 9712 | $0.00 | 19,367.0000 | 84,009,004 | 33.40% | 0.01% |